REVBW logo

Revelation Biosciences (REVBW) Cash From Financing

Annual CFF

$14.03 M
-$1.17 M-7.72%

December 31, 2023


Summary


Performance

REVBW Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherREVBWcash flowmetrics:

Quarterly CFF

$3.74 M
+$3.74 M+100.00%

September 30, 2024


Summary


Performance

REVBW Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherREVBWcash flowmetrics:

TTM CFF

$9.16 M
+$3.74 M+69.09%

September 30, 2024


Summary


Performance

REVBW TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherREVBWcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

REVBW Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-7.7%+100.0%+100.0%
3 y3 years-+100.0%+14.4%
5 y5 years--53.3%+14.4%

REVBW Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-7.7%+75.2%-65.2%-100.0%-14.7%-100.0%
5 y5-year-7.7%+75.2%-65.2%-100.0%-14.7%-100.0%
alltimeall time-7.7%+75.2%-65.2%-100.0%-14.7%-100.0%

Revelation Biosciences Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$3.74 M(>+9900.0%)
$9.16 M(+69.1%)
Jun 2024
-
$0.00(-100.0%)
$5.42 M(0.0%)
Mar 2024
-
$5.42 M(>+9900.0%)
$5.42 M(>+9900.0%)
Dec 2023
$14.03 M(-7.7%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2023
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2022
$15.20 M
-
-
DateAnnualQuarterlyTTM
Jun 2022
-
$0.00(-100.0%)
$10.74 M(0.0%)
Mar 2022
-
$10.74 M(>+9900.0%)
$10.74 M(+34.2%)
Dec 2021
$8.00 M
$0.00(0.0%)
$8.00 M(0.0%)
Sep 2021
-
$0.00(0.0%)
$8.00 M(0.0%)
Jun 2021
-
$0.00(-100.0%)
$8.00 M(0.0%)
Mar 2021
-
$8.00 M
$8.00 M

FAQ

  • What is Revelation Biosciences annual cash flow from financing activities?
  • What is the all time high annual CFF for Revelation Biosciences?
  • What is Revelation Biosciences annual CFF year-on-year change?
  • What is Revelation Biosciences quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Revelation Biosciences?
  • What is Revelation Biosciences quarterly CFF year-on-year change?
  • What is Revelation Biosciences TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Revelation Biosciences?
  • What is Revelation Biosciences TTM CFF year-on-year change?

What is Revelation Biosciences annual cash flow from financing activities?

The current annual CFF of REVBW is $14.03 M

What is the all time high annual CFF for Revelation Biosciences?

Revelation Biosciences all-time high annual cash flow from financing activities is $15.20 M

What is Revelation Biosciences annual CFF year-on-year change?

Over the past year, REVBW annual cash flow from financing activities has changed by -$1.17 M (-7.72%)

What is Revelation Biosciences quarterly cash flow from financing activities?

The current quarterly CFF of REVBW is $3.74 M

What is the all time high quarterly CFF for Revelation Biosciences?

Revelation Biosciences all-time high quarterly cash flow from financing activities is $10.74 M

What is Revelation Biosciences quarterly CFF year-on-year change?

Over the past year, REVBW quarterly cash flow from financing activities has changed by +$3.74 M (+100.00%)

What is Revelation Biosciences TTM cash flow from financing activities?

The current TTM CFF of REVBW is $9.16 M

What is the all time high TTM CFF for Revelation Biosciences?

Revelation Biosciences all-time high TTM cash flow from financing activities is $10.74 M

What is Revelation Biosciences TTM CFF year-on-year change?

Over the past year, REVBW TTM cash flow from financing activities has changed by +$9.16 M (+100.00%)